Section: Molecular Diagnostics

Isothermal Nucleic Acid Amplification: Loop-Mediated Isothermal Amplification (LAMP) and Recombinase Polymerase Amplification (RPA)

Introduction

The rapid and accurate detection of infectious agents is the cornerstone of modern veterinary medicine, enabling timely intervention, herd management, and disease surveillance. While polymerase chain reaction (PCR) revolutionized molecular diagnostics by providing exponential amplification of specific DNA sequences, its reliance on precise thermal cycling equipment limits its deployment to centralized laboratories. This constraint is particularly acute in veterinary practice, where field-based testing of livestock, wildlife, or companion animals is often required under resource-limited conditions. Isothermal nucleic acid amplification methods have emerged to address this gap, allowing amplification of target nucleic acids at a constant temperature, thus eliminating the need for costly thermal cyclers. Among these methods, Loop-Mediated Isothermal Amplification (LAMP) and Recombinase Polymerase Amplification (RPA) have gained prominence for their speed, sensitivity, and operational simplicity. This Master Guide provides a comprehensive overview of the principles, protocols, comparative performance, and veterinary applications of LAMP and RPA, serving as a reference for clinicians, diagnosticians, and researchers.

Historical Context and Development

The development of isothermal amplification technologies arose from a need to democratize nucleic acid testing beyond the confines of well-equipped laboratories. Traditional PCR, first conceptualized by Kary Mullis in 1983, required alternating temperature cycles (denaturation at 94-98°C, annealing at 50-65°C, and extension at 72°C) driven by a thermal cycler. While highly effective, the cost, power requirements, and maintenance of thermal cyclers hindered widespread use in field settings.

LAMP was first described by Notomi et al. in 2000, using the Bacillus stearothermophilus (Bst) DNA polymerase large fragment, which possesses strong strand displacement activity, and a set of four to six primers that recognize six to eight distinct regions on the target sequence. The reaction proceeds at a constant temperature of 60-65°C, producing concatenated stem-loop DNA structures that amplify with high efficiency. The method's simplicity and robustness quickly attracted attention for veterinary diagnostics.

RPA was later introduced by Piepenburg et al. in 2006, inspired by the cellular process of homologous recombination. RPA employs a recombinase enzyme (from E. coli or bacteriophage) to pair oligonucleotide primers with homologous sequences in double-stranded DNA, a single-strand DNA binding protein (SSB) to stabilize the displaced strands, and a strand-displacing DNA polymerase (e.g., Bsu polymerase). The reaction proceeds optimally at 37-42°C, making it uniquely compatible with physiological temperatures and amenable to integration with lateral flow or fluorescent readouts. Both methods have since been adapted for a wide range of pathogens, including viruses, bacteria, and parasites, and are now staples of point-of-care molecular diagnostics in veterinary medicine.

Principles and Mechanisms

LAMP: Loop-Mediated Isothermal Amplification

LAMP relies on the unique properties of Bst DNA polymerase, which lacks exonuclease activity and can displace downstream DNA strands during extension. The primer set includes two outer primers (F3 and B3), two inner primers (FIP and BIP), and optionally two loop primers (LF and LB) that accelerate the reaction. Each inner primer contains sequences complementary to two distinct regions of the target: the forward inner primer (FIP) hybridizes to the F2c region and also includes an F1 sequence, while the backward inner primer (BIP) hybridizes to B2c and includes B1. The outer primers are shorter and initiate strand displacement.

The reaction begins with the annealing of the FIP to the target, followed by extension using Bst polymerase. The extension product is displaced by the F3 primer, which binds upstream and extends, releasing a single-stranded DNA fragment. This fragment forms a stem-loop structure due to the complementary sequences at its ends. The BIP then binds to the loop and initiates extension, generating a hairpin-like structure. Repeated cycling leads to the production of cauliflower-like amplicons with multiple inverted repeats. The incorporation of loop primers further accelerates amplification by binding to loop regions and providing additional initiation sites. The entire process occurs isothermally at 60-65°C, producing up to 10⁹ copies of target within 30-60 minutes. Detection methods include turbidity (magnesium pyrophosphate precipitation), fluorescence (SYBR Green, calcein), and colorimetric dyes.

RPA: Recombinase Polymerase Amplification

RPA mimics in vivo DNA recombination and repair mechanisms. The key enzyme is a recombinase (e.g., UvsX from T4 bacteriophage) that, in the presence of ATP and a crowding agent (polyethylene glycol), assembles into filaments with single-stranded oligonucleotide primers. These filaments scan the double-stranded DNA target and catalyze strand exchange at homologous sequences. Once the primer is paired, a single-strand DNA binding protein (UvsY) stabilizes the displaced strand, and a strand-displacing polymerase (e.g., Bsu large fragment) extends the primer from its 3′ end.

Because the recombinase requires ATP hydrolysis, the reaction mixture includes a creatine kinase/creatine phosphate ATP regeneration system. The optimal temperature is 37-42°C, allowing the reaction to be performed in a water bath, heating block, or even body heat. Exponential amplification occurs as the newly synthesized strands become templates for further primer binding. Amplicon lengths are typically 100-200 base pairs, shorter than LAMP products. Real-time detection employs fluorescent probes (e.g., exo probes with a fluorophore and quencher) that are cleaved by an endonuclease (e.g., nfo) upon target amplification, or lateral flow strips using labeled primers. Total reaction time is often 15-30 minutes, making RPA exceptionally fast.

Laboratory Protocols, Controls, and Quality Assurance

Standard Protocols

Sample Preparation: For both LAMP and RPA, nucleic acid extraction is recommended to remove inhibitors and concentrate targets. Simple boiling methods, commercial spin columns, or magnetic bead-based kits are suitable. Because the enzymes tolerate some inhibitors, crude lysates (e.g., heat-treated swab eluates) can sometimes be used, but validation is essential.

Reaction Mix:

  • LAMP: Typically 1× isothermal buffer (20 mM Tris-HCl, 10 mM (NH₄)₂SO₄, 50 mM KCl, 2 mM MgSO₄, 0.1% Tween 20), 0.8-1.6 mM each dNTP, 0.2 µM each outer primer, 1.6 µM each inner primer, 0.8 µM each loop primer (if used), 1 M betaine (optional), 6-8 mM MgSO₄ (final), 0.32 U/µL Bst 2.0 polymerase, and 1-5 µL template. The total volume is 25 µL. Incubation at 60-65°C for 30-60 min, followed by heat inactivation at 80°C for 5 min.
  • RPA: Commercial kits (e.g., TwistAmp® from TwistDx) contain lyophilized pellets with recombinase, SSB, polymerase, and components. The user rehydrates with rehydration buffer, adds primers (0.4-0.6 µM each), probe (when applicable), template, and magnesium acetate (280 mM final) to initiate the reaction. Incubation at 37-42°C for 15-30 min. Inactivation is optional; products are usually detected directly.

Detection: LAMP amplification can be monitored in real-time using DNA-intercalating dyes (SYTO-9, SYBR Green I) or color change using phenol red (acidification from pyrophosphate). End-point detection uses turbidity (cloudy white precipitate) or gel electrophoresis (ladder-like patterns). RPA is commonly monitored in real-time using fluorogenic probe systems (exo probe with a 5′-FAM and 3′-BHQ1, with an internal tetrahydrofuran residue cleaved by Endonuclease IV). Lateral flow strips detect dual-labeled amplicons (biotin and FAM).

Controls and Quality Assurance

Every diagnostic run must include:

  • Positive control: A known target sequence (synthetic plasmid or attenuated pathogen) to confirm assay function.
  • Negative control: Nuclease-free water or extraction blank to rule out cross-contamination.
  • Internal amplification control (IAC): A non-target sequence (e.g., synthetic RNA or DNA) co-amplified with a separate primer set, verifying that inhibitors are not present in the sample.

To prevent carryover contamination, the following must be implemented: separate pre- and post-amplification areas, use of closed-tube detection (e.g., fluorescence readers), inclusion of dUTP/UNG systems in LAMP (where possible), and regular decontamination of surfaces with bleach or UV light. Because LAMP produces high copy numbers, even trace aerosols can cause false positives. Validation of assays includes determination of limit of detection (LoD), diagnostic sensitivity and specificity, repeatability, and ruggedness across different operators and days.

Comparison with Other Diagnostic Families

Sensitivity and Specificity

  • qPCR remains the gold standard for nucleic acid quantification, with LoD of 1-10 copies/reaction. LAMP and RPA achieve comparable sensitivities when optimized, often reaching 10-100 copies, though LAMP may suffer from non-specific amplification due to primer-dimer or secondary structures. Specificity is high for both if primers are designed to unique regions (e.g., conserved genes of the pathogen). RPA's shorter primers (30-35 nt) may increase mispriming risk, but probe-based detection (exo probe) mitigates this.
  • Conventional PCR is less sensitive (100-1000 copies) and slower (2-3 hours). LAMP and RPA outperform it in speed and ease.
  • ELISA and serology detect host antibodies or pathogen antigens; they have lower sensitivity and cannot distinguish active from past infection. Nucleic acid tests like LAMP/RPA directly detect pathogen genomes, offering higher clinical sensitivity early in infection.
  • Next-generation sequencing offers ultimate breadth but high cost, long turnaround, and computational requirements, making it unsuitable for routine clinical use.

Cost-Effectiveness

Equipment costs: LAMP and RPA require only a heat block or water bath (LAMP) or a simple heating device (RPA can even use body heat). qPCR requires a real-time PCR instrument ($10,000-50,000), while NGS platforms are vastly more expensive. Reagent costs: LAMP and RPA reagents are slightly higher per reaction than conventional PCR ($2-5 vs $1-2) but lower than qPCR probes and kits. However, elimination of thermal cycling reduces electricity and instrument depreciation. Training: Both methods require a moderate level of molecular biology skill for primer design and contamination control, but simplified kits (lyophilized RPA pellets) make them accessible to minimally trained personnel.

Advantages and Disadvantages

Advantages:

  • Speed: RPA in 15-30 min, LAMP in 30-60 min, compared to 1.5-3 h for qPCR.
  • Portability: No need for thermal cycler; can be performed in field settings with portable incubators.
  • Tolerance to inhibitors: Bst polymerase in LAMP is more robust than Taq polymerase; RPA also tolerates biological fluids (saliva, blood, serum) to some extent.
  • Detection versatility: Multiple endpoint detection formats (colorimetric, fluorescent, lateral flow) enable use in low-resource environments.

Disadvantages:

  • Primer design complexity: LAMP requires multiple primers (4-6), and primer design software is essential. RPA primers are longer (30-35 nt) and require careful evaluation for recombinase compatibility.
  • Multiplexing challenges: LAMP and RPA are more difficult to multiplex than qPCR due to overlapping primer interactions, though triplex RPA has been described.
  • False positives: LAMP is prone to carryover contamination due to high amplicon yield; RPA may show non-specific amplification at high template concentrations.
  • Quantitation: Real-time LAMP and RPA can be quantitative, but dynamic range is narrower than qPCR (typically 4-6 logs vs 7-8 logs).

Applications in Veterinary Medicine

The versatility of LAMP and RPA has led to numerous applications across viral, bacterial, parasitic, and even fungal diseases of veterinary importance. Their speed and simplicity make them ideal for outbreak investigations, border screening, and herd-level surveillance.

Viral Diseases:

  • Foot-and-Mouth Disease Virus (FMDV): LAMP assays targeting the 3D polymerase or VP1 gene have been developed for rapid diagnosis in cattle and swine. RPA assays with lateral flow readout have been validated for field detection in endemic regions.
  • African Swine Fever Virus (ASFV): Both LAMP and RPA (targeting the p72 or VP72 gene) are widely used in swine herds, with sensitivities rivaling qPCR.
  • Avian Influenza Virus (AIV): LAMP assays detecting the H5 and H7 subtypes are used in poultry surveillance; RPA has been adapted for rapid screening in migratory birds.
  • Canine Distemper Virus: LAMP targeting the nucleocapsid gene enables diagnosis from conjunctival swabs in dogs, with results within 1 hour.
  • Rabies Lyssavirus: RPA using reverse transcription and a lateral flow dipstick has been developed for ante-mortem diagnosis in saliva, a major advancement for field rabies control.
  • Porcine Reproductive And Respiratory Syndrome Virus (PRRSV): RT-LAMP and RT-RPA are used in swine production systems for early detection.

Bacterial Diseases:

  • Brucella spp.: LAMP targeting the omp31 or IS711 elements aids diagnosis in cattle and small ruminants, differentiating Brucella abortus from B. melitensis.
  • Mycobacterium bovis: Detection of IS1081 or IS6110 by LAMP from bovine nasal swabs supports tuberculosis eradication programs.
  • Leptospira spp.:* LAMP targeting the flaB gene identifies leptospirosis in dogs and livestock; RPA has been explored for use in conjunction with culture.
  • Anaplasma phagocytophilum, Ehrlichia canis: LAMP assays for tick-borne pathogens in companion animals show high sensitivity from blood samples.

Parasitic Diseases:

  • Trypanosoma spp.: LAMP targeting the 18S rRNA gene or satellite DNA is highly effective in African animal trypanosomiasis (Nagana) screening.
  • Theileria parva, Babesia bovis: LAMP assays from bovine blood enable rapid diagnosis of tick-borne hemoparasites, especially in resource-poor settings.
  • Leishmania infantum: LAMP has been applied to canine leishmaniasis using skin or lymph node aspirates.

Fungal Diseases: Less commonly, LAMP assays have been developed for Microsporum canis and Aspergillus fumigatus in veterinary specimens.

Metabolic and Genetic Testing: Isothermal amplification is not typically used for metabolic disease detection, as those rely on biochemical markers. However, genetic detection of antimicrobial resistance genes (e.g., mecA in Staphylococcus pseudintermedius) has been demonstrated using LAMP.

The choice between LAMP and RPA depends on the target, sample matrix, and available equipment. For high-throughput laboratory settings with some infrastructure, LAMP's isothermal temperature (60-65°C) reduces false priming compared to RPA's lower temperature, but RPA's unmatched speed and compatibility with physiological temperature make it ideal for true point-of-care use.

References

1. Notomi, T., Okayama, H., Masubuchi, H., Yonekawa, T., Watanabe, K., Amino, N., & Hase, T. (2000). Loop-mediated isothermal amplification of DNA. Nucleic Acids Research, 28(12), e63.

2. Piepenburg, O., Williams, C. H., Stemple, D. L., & Armes, N. A. (2006). DNA detection using recombination proteins. PLoS Biology, 4(7), e204.

3. Fenner's Veterinary Virology. (2017). 5th ed. MacLachlan, N. J., & Dubovi, E. J. (Eds.). Academic Press.

4. Greene, C. E. (2012). Infectious Diseases of the Dog and Cat. 4th ed. Saunders.

5. Quinn, P. J., Markey, B. K., Leonard, F. C., FitzPatrick, E. S., & Fanning, S. (2011). Veterinary Microbiology and Microbial Disease. 2nd ed. Wiley-Blackwell.

6. OIE (World Organisation for Animal Health). (2022). Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. Chapter on Molecular Diagnostic Methods.

7. Mori, Y., & Notomi, T. (2009). Loop-mediated isothermal amplification (LAMP): A rapid, accurate, and cost-effective diagnostic method for infectious diseases. Journal of Infection and Chemotherapy, 15(2), 62-69.

8. Lobato, I. M., & O'Sullivan, C. K. (2018). Recombinase polymerase amplification: Basics, applications and recent advances. Trends in Analytical Chemistry, 98, 19-35.

9. Kaneko, H., Kawana, T., Fukushima, E., & Suzutani, T. (2007). Tolerance of loop-mediated isothermal amplification to a culture medium and biological substances. Journal of Biochemical and Biophysical Methods, 70(3), 499-501.

10. Li, J., Macdonald, J., & von Stetten, F. (2020). Review: A comprehensive summary of a decade of development of the recombinase polymerase amplification. Analyst, 145(6), 1960-1970.

This Master Guide was authored for zubairkhalid.com/knowledge/diagnostics as a comprehensive resource for veterinary professionals seeking to understand and implement isothermal amplification technologies in clinical practice.